News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 


New Zealand’s wait for scarce shingles vaccine is over

New Zealand’s wait for scarce shingles vaccine is over

ZOSTAVAX™ (Zoster Vaccine Live) has arrived in NZ

Auckland. February 17, 2014 – After a prolonged wait, New Zealand has secured a continuous supply of the world’s first and only vaccine against the painful and debilitating shingles infection, which affects up to 1 in 3 people during their lives.

A new shipment of this scarce vaccine, ZOSTAVAX, has arrived and can be administered by doctors now. The vaccine has been in short supply because it is complex to manufacture and demand is high. Until recently it was primarily available only in the US but in 2013 ZOSTAVAX was added to the National Immunisation Programme in the United Kingdom, where the vaccine is funded for older adults.

“This shipment launches MSD’s long-term programme for ZOSTAVAX. We are taking orders now and anticipate being able to meet the expected demand,” comments Paul Smith, New Zealand Director, MSD.

“Anyone who has ever had chickenpox is at risk of contracting shingles, and the risk and severity of this disease increases sharply from 50 years of age. Chronic pain is the most common complication of shingles and this can last for months, even years.3 Consequently, the impact on shingles sufferers can be devastating, affecting all aspects of their home and work lives. The introduction of this vaccine will now provide a new option to help prevent this debilitating disease.”


In New Zealand, ZOSTAVAX can be administered to individuals that are 50 years or older to reduce the risk of developing shingles and its associated acute and chronic pain. ZOSTAVAX® is a non-funded prescription medicine therefore patient charges will apply for the single dose needed. More information can be found at www.shingles.co.nz

ZOSTAVAX (Zoster Vaccine Live) recently received the Prix Galien 2013 Award for Best Biotechnology Product, specifically for “excellence in scientific innovation to improve the state of human health”. The Prix Galien Award recognises outstanding achievement in the development of new medicines.
Ends

About MSD
Today's MSD is working to help the world be well. Through our medicines, vaccines, biologic therapies, and consumer and animal products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching programs that donate and deliver our products to the people who need them. MSD. Be Well. For more information, visit: www.msd.com

About the Galien Foundation

The Galien Foundation fosters, recognises and rewards excellence in scientific innovation to improve the state of human health. Its vision is to be the catalyst for the development of the next generation of innovative treatment and technologies that will impact human health and save lives.

The Foundation oversees and directs activities in the USA for the Prix Galien, an international award that recognizes outstanding achievements in improving the human condition through the development of innovative therapies. The Prix Galien was created in 1970 in honour of Galen, the father of medical science and modern pharmacology. Worldwide, the Prix Galien is regarded as the equivalent of the Nobel Prize in biopharmaceutical research.

ends

© Scoop Media

 
 
 
 
 
Culture Headlines | Health Headlines | Education Headlines

 

Snell Sale Peters Out: Singlet Withdrawn From Sale

“We believe the item was offered for sale in good faith, but our inquiries have shown that the singlet is not the one worn by Peter Snell at the 1964 Tokyo Olympic Games.” More>>

ALSO:

Bodega: Venue Closing At The End Of The Year, After 25 Years Of Music

"It is with considerable sadness that, for reasons beyond our control, we regret to announce the closure of Bodega’s doors at the end of this year, after 25 years of faithful and committed service to live music in Wellington." More>>

Scoop Review Of Books: Women At The Centre

In the first chapter of her epic History of New Zealand Women, Barbara Brookes places a version of the Māori creation story alongside that of the Pākehā colonists, setting the scene for how each society saw women. The contrast is startling. More>>

In Auckland Art Gallery: A Tour Of Duty

I had already started my journey through the exhibited collections when an audio announcement about a guided tour to embark shortly from the foyer was made, I decided to join in. Why not? More>>

Art: ‘Holiday’ Wins IHC Art Awards

An intricate embroidered cushion by Wellington artist Jo-Anne Tapiki has won the 2016 IHC Art Awards and $5000. Jo-Anne started working from IHC’s Arts on High studio in Lower Hutt 18 months ago and this is the first time she has entered the competition. More>>

‘Quasi’: Christchurch Art Gallery Reveals Rooftop Sculpture

Christchurch-born and internationally renowned artist Ronnie van Hout has had a huge hand in Christchurch Art Gallery's latest outdoor installation. More>>

Get More From Scoop

 
 

LATEST HEADLINES

 
 
 
 
Health
Search Scoop  
 
 
Powered by Vodafone
NZ independent news